Major drug companies agree to price negotiations with US government
Oct 03, 2023
Ten drugs have been chosen for price negotiations by the Centers for Medicare & Medicaid Services.
Biden names former North Carolina health secretary to be new CDC director
Jun 16, 2023
Mandy Cohen, MD, comes with credentials that should help her lead the beleaguered agency, criticized for its response to the COVID-19 pandemic.
Racial and ethnic disparities seen in use of hospice
Dec 18, 2023
Older age was associated with lower odds of short length of stay in those dually eligible for Medicare and Medicaid.
Sociodemographics tied to rehab use during critical illness hospitalization
May 10, 2024
Dual Medicare and Medicaid eligibility and rural residence were linked to lower odds of physical and occupational therapy receipt.
Almost 1 in 4 people disenrolled from Medicaid are now uninsured
Apr 12, 2024
Nearly a quarter of Americans who lost their pandemic-era Medicaid coverage say they’re now without any health insurance, a new survey finds.
Healthcare spending growth projected to outpace GDP to 2032
Jun 13, 2024
National health expenditures are projected to have increased 7.5% in 2023, when the COVID-19 public health emergency ended.
Paperwork causing many Americans to lose Medicaid coverage, White House warns
Jul 31, 2023
Changes are happening now because a prohibition on removing Medicaid coverage during the pandemic has now been lifted.
New federal rule means hospitals need written consent for pelvic, prostate exams
Apr 01, 2024
The HHS also issued a new set of guidelines clarifying a longstanding requirement that hospitals must obtain written informed consent as a condition for being reimbursed by Medicare and Medicaid.
Feds urge states to slow down on dropping people from Medicaid
Jun 13, 2023
States now are reevaluating Medicaid eligibility after having been prohibited from dropping people during the early years of the pandemic.
Sanofi follows Lilly, Novo Nordisk in cutting insulin prices
Mar 17, 2023
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month.